nanoemulsion

NanoBio

NanoBio Gets Up To $10M From Feds To Develop Flu Vaccine

NanoBio Corp. will get an initial contract of $5.5 million and up to $5 million more to devleop its nanoemulsion technology to improve the performance of flu vaccines.

WWJ Newsradio 950–10/29/2013

nanobio

NanoBio Closes $11 Million Series C Financing

NanoBio Corp. announced Wednesday the closing of an $11 million Series C financing, including full participation from its existing investor syndicate.

WWJ Newsradio 950–11/28/2012

nanobio

NanoBio Publishes Study Results For Intranasal Nanoemulsion Vaccine

Ann Arbor-based NanoBio Corp. says newly published experimental data shows that its nanoemulsion-based flu vaccine has elicited robust immunity to the flu in animal tests on ferrets.

WWJ Newsradio 950–07/20/2011

NanoBio Gets Patent On Cold Sore Product

Ann Arbor-based NanoBio Corp. said Tuesday that it had been awarded its seventh United States patent covering its novel nanoemulsion technology. The new claims encompass methods of treating Herpes Simplex I infections, including herpes labialis, […]

08/03/2010

Follow

Get every new post delivered to your Inbox.

Join 2,311 other followers